Literature DB >> 23510064

Immunological cells and functions in Gaucher disease.

Manoj Kumar Pandey1, Gregory A Grabowski.   

Abstract

The macrophage (MΦ) has been the focus of causality, research, and therapy of Gaucher disease, but recent evidence casts doubt its solitary role in the disease pathogenesis. The excess of glucosylceramide (GC) in such cells accounts for some of the disease manifestations. Evidence of increased expression of C-C and C-X-C chemokines (i.e., CCL2,CXCL1, CXCL8) in Gaucher disease could be critical for monocyte transformation to inflammatory subsets of macrophages and dendritic cells (DC) as well as neutrophil (PMNs) recruitment to visceral organs. These immune responses could be essential for activation of T- and B-cell subsets, and the induction of numerous cytokines and chemokines that participate in the initiation and propagation of the molecular pathogenesis of Gaucher disease. The association of Gaucher disease with a variety of cellular and humoral immune responses is reviewed here to provide a potential foundation for expanding the complex pathophysiology of Gaucher disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510064      PMCID: PMC3661296          DOI: 10.1615/critrevoncog.2013004503

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  288 in total

1.  Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation).

Authors:  K P Zimmer; P le Coutre; H M Aerts; K Harzer; M Fukuda; J S O'Brien; H Y Naim
Journal:  J Pathol       Date:  1999-08       Impact factor: 7.996

Review 2.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 3.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

Review 4.  Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.

Authors:  William R Heath; Gabrielle T Belz; Georg M N Behrens; Christopher M Smith; Simon P Forehan; Ian A Parish; Gayle M Davey; Nicholas S Wilson; Francis R Carbone; Jose A Villadangos
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

Review 5.  CD1 antigen presentation: how it works.

Authors:  Duarte C Barral; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

6.  Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice.

Authors:  Manabu Kinoshita; Takefumi Uchida; Atsushi Sato; Masahiro Nakashima; Hiroyuki Nakashima; Satoshi Shono; Yoshiko Habu; Hiromi Miyazaki; Sadayuki Hiroi; Shuhji Seki
Journal:  J Hepatol       Date:  2010-07-14       Impact factor: 25.083

7.  Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis.

Authors:  S Ichikawa; H Sakiyama; G Suzuki; K I Hidari; Y Hirabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

8.  Gaucher or pseudo-Gaucher? The challenge of several diseases colliding in a pediatric patient.

Authors:  Mariana M Cajaiba; Miguel Reyes-Múgica
Journal:  Hum Pathol       Date:  2008-12-11       Impact factor: 3.466

9.  Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases.

Authors:  Naotake Tsuboi; Kenichi Asano; Michael Lauterbach; Tanya N Mayadas
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  28 in total

Review 1.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.

Authors:  Hagit N Baris; Ian J Cohen; Pramod K Mistry
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

2.  Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment.

Authors:  Elena Gras-Colomer; María Amparo Martínez-Gómez; Ana Moya-Gil; Miguel Fernandez-Zarzoso; Matilde Merino-Sanjuan; Mónica Climente-Martí
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

3.  Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.

Authors:  Shaalee Dworski; Ping Lu; Aneal Khan; Bruno Maranda; John J Mitchell; Rossella Parini; Maja Di Rocco; Boris Hugle; Makoto Yoshimitsu; Bo Magnusson; Balahan Makay; Nur Arslan; Norberto Guelbert; Karoline Ehlert; Andrea Jarisch; Janet Gardner-Medwin; Rawane Dagher; Maria Teresa Terreri; Charles Marques Lorenco; Lilianna Barillas-Arias; Pranoot Tanpaiboon; Alexander Solyom; James S Norris; Xingxuan He; Edward H Schuchman; Thierry Levade; Jeffrey A Medin
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-12-01       Impact factor: 5.187

Review 4.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

Review 5.  Gaucher disease - more than just a rare lipid storage disease.

Authors:  Jaehyeok Roh; Subbaya Subramanian; Neal J Weinreb; Reena V Kartha
Journal:  J Mol Med (Berl)       Date:  2022-01-23       Impact factor: 4.599

Review 6.  Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson's disease.

Authors:  Laetitia Francelle; Joseph R Mazzulli
Journal:  Brain Res       Date:  2022-01-19       Impact factor: 3.610

7.  Type I Gaucher disease with bullous pemphigoid and Parkinson disease: A case report.

Authors:  Damien Le Peillet; Virginie Prendki; Véronique Trombert; Emmanuel Laffitte; Frédéric Assal; Jean Luc Reny; Christine Serratrice
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

8.  TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease.

Authors:  Margarita Ivanova; Julia Dao; Lauren Noll; Jacqueline Fikry; Ozlem Goker-Alpan
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

9.  The prognostic value of the serum ferritin in a southern Brazilian cohort of patients with Gaucher disease.

Authors:  Tiago Koppe; Divair Doneda; Marina Siebert; Livia Paskulin; Matheus Camargo; Kristiane Michelin Tirelli; Filippo Vairo; Liane Daudt; Ida Vanessa D Schwartz
Journal:  Genet Mol Biol       Date:  2016-03       Impact factor: 1.771

10.  Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.

Authors:  Renuka Pudi Limgala; Chidima Ioanou; Matthew Plassmeyer; Mark Ryherd; Lina Kozhaya; Lauren Austin; Cem Abidoglu; Derya Unutmaz; Oral Alpan; Ozlem Goker-Alpan
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.